MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
19.79
+1.28 (6.92%)
At close: Mar 9, 2026, 4:00 PM EDT
19.79
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $863.66 million as of March 9, 2026.
Market Cap
863.66M
Enterprise Value
645.12M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.79
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $863.66M, an increase of 22.63%. That is a compound annual growth rate of 77.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 807.80M | 5.38% |
| Dec 31, 2025 | 766.56M | 8.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 840.78M |
| Sana Biotechnology | 840.63M |
| Evommune | 835.39M |
| BridgeBio Oncology Therapeutics | 833.94M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |
| Omeros | 818.19M |
| MannKind | 804.14M |